This is a rare genetic condition where the body doesn't make enough of an enzyme called pyruvate carboxylase. This enzyme helps the body make energy. Without it, the body builds up lactic acid, which can cause serious problems like seizures and breathing difficulties.
Every report comes from a Lived member, sent anonymously.
Have you tried Potassium Citrate for Pyruvate Carboxylase Deficiency?
Pyruvate carboxylase deficiency is a rare inherited metabolic disorder in which the body lacks enough working pyruvate carboxylase, an enzyme inside the cell's energy-producing structures (mitochondria). The enzyme helps the body make glucose, keeps the cell's energy cycle running and supports the production of brain chemical messengers and myelin, the protective coating around nerve fibers. Without it, lactic acid and other harmful substances build up in the blood (lactic acidosis), and the brain and nervous system are especially vulnerable to damage. Doctors recognize three types, and they differ greatly. Type A begins in infancy with developmental delay, poor growth, weak muscle tone, seizures and repeated episodes of acid buildup that can cause vomiting, extreme tiredness and difficulty breathing. Type B, the most severe, appears at or soon after birth with severe acidosis, high blood ammonia, low blood sugar and liver failure. Type C is the mildest and rarest: development is normal or only mildly delayed, and acid buildup comes in episodes, often during an illness. Even type C can bring movement, walking or speech difficulties, so it is milder rather than harmless.
The cause is a change (variant) in both copies of the PC gene (named for pyruvate carboxylase), which carries the instructions for the enzyme. The condition is inherited in an autosomal recessive pattern: each parent usually carries one altered copy without having symptoms. When both parents are carriers, each pregnancy has a 25% chance of a child with the condition, a 50% chance of a child who is a carrier and a 25% chance of a child with neither variant. It is estimated to occur in about 1 in 250,000 births worldwide, though type A is more common in some Algonkian First Nations communities in eastern Canada. The genetic cause is present from birth, but day-to-day stresses can set off episodes. Illness and going too long without food (fasting) are the best-known triggers, because both push the body to rely on the energy pathway that the missing enzyme normally supports.
The condition is usually suspected in a baby or young child with lactic acidosis, poor growth, developmental delay or seizures. Sometimes newborn screening raises the possibility. Blood tests typically show high lactate, ketones and sometimes ammonia, along with a characteristic pattern of amino acids. Because several other inherited energy disorders, including pyruvate dehydrogenase deficiency and Leigh syndrome, can look similar, these results point toward the diagnosis rather than settling it. The diagnosis is confirmed by genetic testing that finds disease-causing variants in both copies of the PC gene, or by a lab test showing very low pyruvate carboxylase enzyme activity. Brain imaging may show changes in the brain's white matter. Identifying the family's specific variants also makes carrier testing for relatives and testing in future pregnancies possible.
There is currently no cure and no treatment approved by the US Food and Drug Administration (FDA) for pyruvate carboxylase deficiency. Care aims to prevent and quickly treat episodes of acid buildup and to support growth and development, usually led by a metabolic (biochemical genetics) specialist working with neurology, nutrition and other teams. Avoiding fasting is central, because going without food can set off a crisis. A ketogenic diet (very high fat, very low carbohydrate) should not be used. During a crisis, treatment happens in the hospital with intravenous (IV) fluids containing glucose, hydration and medicine to correct the acid buildup. For longer-term care, doctors may prescribe citrate and aspartate, building blocks for the energy cycle, along with vitamins and cofactors such as biotin. These can steady blood test results but have not been shown to prevent or reverse the neurological problems, and biotin has generally helped little. Triheptanoin, a specially made oil that supplies an alternative fuel, has produced mixed results: some people, mainly with type C, have had fewer crises and better exercise tolerance, while results in types A and B have largely been disappointing. Its use here is experimental. Liver transplantation has improved blood chemistry in a few reported children but is not a standard option. Seizure medicines, therapy services and nutritional support address other effects of the condition.
The outlook depends heavily on the type. With types A and B, the condition is usually life-limiting: most children with type A die in infancy or early childhood, and babies with type B typically survive only months. For these families, care often focuses on comfort, feeding, seizure control and support alongside medical treatment. A few longer survivors have been described. People with type C usually have a much better course, and survival into adulthood has been reported. Life with type C often means planning around illness: regular meals, a sick-day plan agreed with the metabolic team and quick treatment when a child cannot eat. Some children have delays in speech or movement that benefit from therapy services. Because so few people with type C have been described, long-term outcomes are not well known. Regular follow-up tracks growth, development, blood tests and how well treatment is working. Genetic counseling helps parents understand the chance for future children and the testing options available.
Ask about an evaluation for a metabolic disorder when an infant or young child has unexplained lactic acidosis, poor growth, developmental delay or seizures, especially if a sibling had a similar illness. For someone already diagnosed, contact the metabolic team promptly, the same day, when illness, vomiting or poor feeding means they cannot eat or keep fluids down, since they may need IV glucose before acid builds up. Seek emergency care right away for labored or very fast breathing, unusual sleepiness or difficulty waking, or a seizure, and bring any emergency letter from the metabolic team.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Pyruvate Carboxylase Deficiency is like, what's helped you, or ask the community a question.